The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells

Cellular Physiology and Biochemistry

Volumn 40, Issue 1-2, 2016, Pages 183-194

  Yu, Fujun ^a,b,c   Yang, Jianhuan ^d   Huang, Kate ^a   Pan, Xiaodong ^a   Chen, BiCheng ^a   Dong, Peihong ^a   Zheng, Jianjian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Hepatic stellate cell; MicroRNA 378a; TGF 2

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; MICRORNA; MICRORNA 378A; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AZACITIDINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; MIRN378 MICRORNA, HUMAN; MIRN378 MICRORNA, RAT;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; HEPATIC STELLATE CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; RAT; ANIMAL; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; LIVER CIRRHOSIS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; SPRAGUE DAWLEY RAT;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; AZACITIDINE; BASE SEQUENCE; CELL CYCLE; CELL PROLIFERATION; COLLAGEN TYPE I; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; MICRORNAS; PROMOTER REGIONS, GENETIC; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84997523682     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000452536     Document Type: Article

References (43)

1. Schuppan D, Krebs A, Bauer M, Hahn EG: Hepatitis C and liver fibrosis. Cell Death Differ 2003;10:S59-67.
2. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
3. Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM: Changing the pathogenetic roadmap of liver fibrosis?. Where did it start; where will it go?. J Gastroenterol Hepatol 2008;23:1024-1035.
4. Kong X, Horiguchi N, Mori M, Gao B: Cytokines and STATs in Liver Fibrosis. Front Physiol 2012;3:69.
5. Zheng J, Lin Z, Dong P, Lu Z, Gao S, Chen X, Wu C, Yu F: Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med 2013;32:17-24.
6. Friedman SL: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.
7. Zhang X, Tan Z, Wang Y, Tang J, Jiang R, Hou J, Zhuo H, Wang X, Ji J, Qin X, Sun B: PTPRO-associated hepatic stellate cell activation plays a critical role in liver fibrosis. Cell Physiol Biochem 2015;35:885-898.
8. Xiao Y, Qu C, Ge W, Wang B, Wu J, Xu L, Chen Y: Depletion of thymosin beta4 promotes the proliferation, migration, and activation of human hepatic stellate cells. Cell Physiol Biochem 2014;34:356-367.
9. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner AM: Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett 2001;502:4-10.
10. Schickel R, Boyerinas B, Park SM, Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008;27:5959-5974.
11. Li G, Li J, Li C, Qi H, Dong P, Zheng J, Yu F: MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1. Cell Physiol Biochem 2016;38:1544-1552.
12. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
13. Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B, Yu F: Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation - a novel mechanism suppressing liver fibrosis. FEBS J 2014;281:88-103.
14. Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ: miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol 2015;50:480-490.
15. Yu F, Guo Y, Chen B, Dong P, Zheng J: MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest 2015;95:781-789.
16. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N: Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 2011;412:74-79.
17. Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A, Pizer B, Clerico A, De Grazia A, Pizzuti A, Moles A, Dominici C: Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 2014;14:880.
18. Ikeda K, Horie-Inoue K, Ueno T, Suzuki T, Sato W, Shigekawa T, Osaki A, Saeki T, Berezikov E, Mano H, Inoue S: miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci Rep 2015;5:13170.
19. Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A: Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer 2014;50:1207-1221.
20. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, Lin L: Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012;17:410-423.
21. Krist B, Florczyk U, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J: The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology. Int J Endocrinol 2015;2015:281756.
22. Nagalingam RS, Sundaresan NR, Noor M, Gupta MP, Solaro RJ, Gupta M: Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor beta (TGFbeta1)-dependent paracrine mechanism. J Biol Chem 2014;289:27199-27214.
23. Yao QY, Xu BL, Wang JY, Liu HC, Zhang SC, Tu CT: Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med 2012;12:156.
24. Weiskirchen R, Gressner AM: Isolation and culture of hepatic stellate cells. Methods Mol Med 2005;117:99-113.
25. Ji W, Yang L, Yu L, Yuan J, Hu D, Zhang W, Yang J, Pang Y, Li W, Lu J, Fu J, Chen J, Lin Z, Chen W, Zhuang Z: Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 2008;29:1267-1275.
26. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002;7:d793-807.
27. Li ZJ, Ou-Yang PH, Han XP: Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal 2014;26:141-148.
28. Yang Y, Wang LL, Wang HX, Guo ZK, Gao XF, Cen J, Li YH, Dou LP, Yu L: The epigenetically-regulated miR-663 targets H-ras in K-562 cells. FEBS J 2013;280:5109-5117.
29. Lehmann U, Hasemeier B, Romermann D, Muller M, Langer F, Kreipe H: [Epigenetic inactivation of microRNA genes in mammary carcinoma]. Verh Dtsch Ges Pathol 2007;91:214-220.
30. Yang Y, Wang LL, Li YH, Gao XN, Liu Y, Yu L: Effect of CpG island methylation on microRNA expression in the k-562 cell line. Biochem Genet 2012;50:122-134.
31. Li LH, Gao Q, Wang XY, Guo ZJ: [miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin-like growth factor 1 receptor]. Zhonghua Gan Zang Bing Za Zhi 2013;21:609-613.
32. Bellafante E, Murzilli S, Salvatore L, Latorre D, Villani G, Moschetta A: Hepatic-specific activation of peroxisome proliferator-activated receptor gamma coactivator-1beta protects against steatohepatitis. Hepatology 2013;57:1343-1356.
33. Wang P, Gu Y, Zhang Q, Han Y, Hou J, Lin L, Wu C, Bao Y, Su X, Jiang M, Wang Q, Li N, Cao X: Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J Immunol 2012;189:211-221.
34. Friedman SL: Liver fibrosis: from mechanisms to treatment. Gastroenterol Clin Biol 2007;31:812-814.
35. Liu X, Hu H, Yin JQ: Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 2006;26:8-22.
36. He Y, Huang C, Sun X, Long XR, Lv XW, Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012;24:1923-1930.
37. Gressner AM, Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.
38. Lang Q, Liu Q, Xu N, Qian KL, Qi JH, Sun YC, Xiao L, Shi XF: The antifibrotic effects of TGF-beta1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun 2011;409:448-453.
39. Carrington LM, Albon J, Anderson I, Kamma C, Boulton M: Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest Ophthalmol Vis Sci 2006;47:1886-1894.
40. Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, Zangrilli JG, Peters SP: Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004;34:437-444.
41. Lee SY, Chuang JH, Huang CC, Chou MH, Wu CL, Chen CM, Hsieh CS, Chen CL: Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia. J Pediatr Surg 2004;39:702-708.
42. Hill C, Flyvbjerg A, Rasch R, Bak M, Logan A: Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 2001;170:647-651.
43. Shimada H, Staten NR, Rajagopalan LE: TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells. J Hepatol 2011;54:521-528.